查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1995170

關節鏡市場：依產品類型、病患類型、應用程式和最終用戶分類－2026-2032年全球市場預測

Arthroscopy Market by Product Type, Patient Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年關節鏡市值為 66.5 億美元，預計到 2026 年將成長至 69.8 億美元，複合年成長率為 5.14%，到 2032 年將達到 94.5 億美元。

主要市場統計數據
基準年 2025 66.5億美元
預計年份：2026年 69.8億美元
預測年份 2032 94.5億美元
複合年成長率 (%) 5.14%

本導言部分深入探討了臨床實踐、醫療設備創新和醫療保健服務模式如何融合，從而重新定義現代關節鏡的結果。

由於微創器械、影像清晰度和手術全期系統整合技術的進步，關節鏡已從一種小眾手術方式發展成為整形外科和運動醫學診療流程中不可或缺的重要組成部分。由於關節鏡手術具有組織保留性好、恢復快、感染風險低等優點，臨床醫生現在通常更傾向於選擇關節鏡技術而非開放性手術。為此，醫療設備開發商和醫療系統正優先研發能夠提高手術精度並減少手術操作差異的創新技術。

數位視覺化技術的進步、向門診護理的轉變以及對價值驅動方法的需求，如何共同改變關節鏡手術實踐和醫療設備。

在關節鏡手術領域，變革正在發生，其驅動力包括技術融合、門診治療模式的轉變以及外科醫生對整合系統的日益成長的需求。成像和視覺化技術已超越單純的光學性能，發展到涵蓋數位擴展和連接功能，從而實現術中資料收集、遠端協作以及與醫院資訊系統的兼容。這些功能正在改變外科醫生的工作流程，並催生對模組化系統的需求，這種系統無需更換整個平台即可進行升級。

評估美國關稅趨勢將如何影響整個關節鏡系統的供應鏈、籌資策略和採購實踐。

美國預計將徵收的關稅可能會影響關節鏡供應鏈、籌資策略以及進口零件和成品的成本趨勢。依賴跨境生產來製造關節鏡、刨削器、泵浦或高頻發生器的製造商將直接受到投入成本變化的影響，被迫重新評估供應商合約並考慮近岸外包方案以降低風險。為此，採購團隊正在評估替代供應商、調整庫存策略並探索區域製造夥伴關係，以維持獲利能力。

將產品架構、患者人口統計特徵、解剖結構適應性以及最終用戶方面的差異與策略性產品和服務決策聯繫起來的關鍵細分洞察。

對產品細分的詳細分析揭示了植入、器械和系統在研發和臨床需求模式上的差異。植入在材料科學和固定方法方面不斷發展，以滿足對耐用性和生物相容性的期望。器械種類繁多，從常用配件到先進的關節鏡、泵、射頻探頭和刨削器，應有盡有，這些器械必須與外科醫生的技術和視覺化平台無縫整合。系統則是一個獨特的類別，專注於流體管理、射頻平台和視覺化解決方案，這些共同構成了現代關節鏡手術技術的基礎。

美洲、歐洲、中東和非洲以及亞太地區的採用趨勢、監管協調和區域因素如何影響商業策略。

區域趨勢對整個關節鏡領域的應用模式、監管環境和投資重點都有顯著影響。在美洲，完善的報銷機制、豐富的經驗豐富的關節鏡醫生資源以及不斷完善的門診醫療基礎設施，推動了對高效系統的需求，這些系統能夠提供可預測的治療效果並支持更高的手術容量。在該地區營運的市場參與企業必須在創新、注重成本的採購週期以及嚴格的臨床數據要求之間取得平衡。

模組化平台、與治療結果掛鉤的服務模式以及優先考慮臨床合作的競爭策略是確保長期採用的關鍵要素。

關節鏡領域的主要企業正著力於幾項策略重點：系統互通性、全生命週期服務交付以及產生支持臨床價值的證據。他們正投資於模組化平台，以實現可視化、流體管理或能量輸送組件的分階段升級，從而降低醫療機構設備現代化的門檻。服務模式正從被動維護向主動支持和基於結果的合約轉變，將供應商獎勵與手術效率和患者康復指標掛鉤。

為製造商和醫療保健提供者提供切實可行的建議，以增強韌性、加快臨床部署，並使價值提案與醫療保健服務優先事項保持一致。

行業領導者應採取多管齊下的策略，以增強韌性、支持臨床部署，並使商業模式與不斷變化的醫療服務需求保持一致。首先，應優先考慮模組化設計和開放式架構，以實現分階段升級並降低買方的整體擁有成本 (TCO)。這種方法可以降低部署門檻，延長已部署設備的使用壽命，並擴大相關產品和耗材的交叉銷售機會。

採用透明且多方面的調查方法，結合監管審查、臨床文獻、相關人員訪談和技術產品評估來支持結論。

本研究途徑結合了對公開監管文件、同行評審臨床文獻和醫療設備認證通知的系統性回顧，以及對外科、採購和經營團隊等相關相關人員的重點訪談。在評估醫療設備技術時，我們根據技術規格、產品描述和供應商資訊披露的信息，整理了功能集和互通性特徵。監管和政策分析納入了近期發布的指導意見和關稅公告，以評估其對供應鏈和跨境貿易的潛在影響。

一項橫斷面趨勢整合研究突顯了關節鏡。

總之，關節鏡正處於技術成熟與醫療服務模式變革的交會點。視覺化、液體管理和器械技術的進步使得手術更加精準高效，而向門診治療和價值主導採購的轉變正在重塑採購邏輯。供應鏈的脆弱性和政策的轉變加速了對製造地和產品架構的考量，而競爭優勢也越來越依賴服務模式、訓練系統和可驗證的臨床價值。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：關節鏡市場：依產品類型分類

  • 植入
  • 裝置
    • 配件
    • 關節鏡
    • 泵浦
    • 高頻探頭
    • 刮鬍刀
  • 系統
    • 體液管理系統
    • 射頻系統
    • 視覺化系統

第9章：依患者類型關節鏡市場

  • 成人
  • 兒童

第10章：關節鏡市場：依應用領域分類

  • 踝
  • 彎頭
  • 髖關節
  • 膝蓋
  • 肩膀
  • 手腕

第11章：關節鏡市場：依最終用戶分類

  • 門診手術中心
  • 醫院和診所

第12章：關節鏡市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：關節鏡市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：關節鏡市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國關節鏡市場

第16章：中國關節鏡市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Arthrex Inc.
  • Auxein Medical
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Bioventus, LLC
  • Boston Scientific Corporation
  • CONMED Corporation
  • Endoch Medical
  • Endomed Systems GmbH
  • Flexion Therapeutics Inc.
  • GPC Medical Ltd.
  • Hyalex Orthopaedics, Inc.
  • Johnson & Johnson Services Inc.
  • Karl Storz SE & Co. KG
  • MJ Surgical
  • Medtronic plc
  • Mercator Medical SA
  • Norm Medical
  • Olympus Corporation
  • Richard Wolf GmbH
  • Shagun Cares Inc.
  • Sklar Surgical Instruments
  • Smith & Nephew plc
  • Stryker Corporation
  • Visakha Healthcare India Pvt Ltd
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-EC2E133E341A

The Arthroscopy Market was valued at USD 6.65 billion in 2025 and is projected to grow to USD 6.98 billion in 2026, with a CAGR of 5.14%, reaching USD 9.45 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.65 billion
Estimated Year [2026] USD 6.98 billion
Forecast Year [2032] USD 9.45 billion
CAGR (%) 5.14%

An incisive introduction to how clinical practice, device innovation, and care delivery models are converging to redefine contemporary arthroscopy outcomes

Arthroscopy has evolved from a niche surgical approach into a foundational component of orthopedic and sports medicine care pathways, driven by advances in minimally invasive tools, visualization fidelity, and perioperative systems integration. Clinicians now routinely favor arthroscopic techniques where tissue-sparing access offers faster recovery and lower infection risk compared with open procedures, which has prompted device developers and health systems to prioritize innovations that enhance precision and reduce procedure variability.

Consequently, investment in arthroscopy spans hardware improvements, such as next-generation scopes and shavers, and procedural ecosystems, including fluid management and radiofrequency systems that stabilize the surgical field. Concurrently, training, reimbursement structures, and outpatient facility capabilities are shifting to support higher volumes of short-stay procedures, thereby reshaping clinical workflows and capital allocation. As this section unfolds, readers will gain a concise orientation to the forces influencing device design, clinical adoption, and the evolving interplay between technology and care delivery in arthroscopic practice.

How digital visualization advances, outpatient migration, and value-based imperatives are jointly transforming arthroscopy practice and device requirements

The landscape of arthroscopy is experiencing transformative shifts driven by technological convergence, procedural migration to outpatient settings, and heightened surgeon expectations for integrated systems. Imaging and visualization have moved beyond improved optics to include digital augmentation and connectivity that enable intraoperative data capture, remote collaboration, and compatibility with hospital information systems. These capabilities are altering surgeon workflows and creating demand for modular systems that can be upgraded without replacing entire platforms.

At the same time, health care delivery trends are accelerating the transition of elective arthroscopic procedures into ambulatory environments, prompted by cost containment pressures and patient preference for reduced exposure and faster recovery. This shift reinforces the need for compact, portable, and robust instrumentation as well as simplified sterilization and disposable options. Additionally, the emphasis on value-based care has intensified scrutiny of implant selection and procedural efficiency, encouraging manufacturers to demonstrate clear clinical benefits and streamlined supply chain solutions. Taken together, these transformative shifts are raising the bar for interoperability, lifecycle support, and evidence-based design, compelling stakeholders across surgical departments, ambulatory centers, and device companies to align investments with the new standard of care.

Assessment of how potential United States tariff developments could reshape supply chains, sourcing strategies, and procurement behavior across the arthroscopy ecosystem

Prospective tariff measures introduced by the United States can influence arthroscopy supply chains, sourcing strategies, and cost dynamics for imported components and finished devices. Manufacturers that rely on cross-border manufacturing for scopes, shavers, pumps, or radiofrequency generators face a direct impact on input costs, prompting reassessment of supplier contracts and consideration of nearshoring options to mitigate exposure. In response, procurement teams are evaluating alternative sourcing, adjusting inventory policies, and exploring regional manufacturing partnerships to preserve margin stability.

Beyond direct cost pressures, tariffs can accelerate broader strategic shifts. Device companies are likely to prioritize design for manufacturability to reduce reliance on tariff-sensitive components and to increase the use of standardized parts across product families. Meanwhile, hospitals and ambulatory centers may reassess total cost of ownership when selecting systems, favoring vendors that offer bundled service agreements or local support networks that absorb some logistical uncertainty. Importantly, regulatory alignment and customs facilitation become critical factors for exporters aiming to preserve market access, while policy uncertainty itself may slow capital purchases until tariff trajectories are clearer. Thus, the cumulative effect of tariffs extends beyond price effects to influence sourcing resilience, product architecture, and commercial strategies across the value chain.

Key segmentation insights linking product architecture, patient cohorts, anatomical applications, and end user distinctions to strategic product and service decisions

A granular view of product segmentation reveals differentiated development and clinical demand patterns across implants, instruments, and systems. Implants continue to evolve in material science and fixation methods to meet durability and biocompatibility expectations. Instruments encompass a spectrum from common accessories to sophisticated arthroscopes, pumps, radiofrequency probes, and shavers that must integrate seamlessly with surgeon technique and visualization platforms. Systems represent a distinct category focused on fluid management, radiofrequency platforms, and visualization solutions that together form the procedural backbone for modern arthroscopy.

Patient segmentation highlights divergent clinical pathways and device requirements between adult and pediatric populations, with pediatric care emphasizing size-adapted instrumentation, lower-profile scopes, and specific procedural protocols to protect growth plates and long-term function. Application-based differentiation spans anatomical focus areas such as ankle, elbow, hip, knee, shoulder, and wrist, each with unique instrumentation demands, ergonomic considerations, and rehabilitation protocols that influence device design and service offerings. End user segmentation identifies ambulatory surgery centers and hospitals and clinics as distinct operating environments: ambulatory centers prioritize compact systems, streamlined turnover, and cost-effective disposables, while hospitals place greater value on high-capacity visualization platforms, comprehensive service agreements, and integration with broader perioperative infrastructure. Together, these segmentation lenses inform product roadmaps, clinical training programs, and commercial approaches that align with procedural complexity and care setting requirements.

Regional forces shaping adoption, regulatory alignment, and commercial strategy across the Americas, Europe Middle East & Africa, and Asia-Pacific environments

Regional dynamics exert a powerful influence on uptake patterns, regulatory pathways, and investment priorities across the arthroscopy landscape. In the Americas, established reimbursement frameworks, a large base of experienced arthroscopic surgeons, and growing ambulatory infrastructure drive demand for efficient systems that deliver predictable outcomes and support higher procedural throughput. Market participants operating in this region must balance innovation with cost-conscious procurement cycles and rigorous clinical data requirements.

Europe, Middle East & Africa presents a heterogeneous terrain where regulatory harmonization efforts coexist with pronounced country-level variability in hospital capabilities and payer models. In this region, adoption often hinges on demonstrating improved clinical outcomes and compatibility with existing hospital ecosystems, while emerging markets emphasize affordability and local service support. Asia-Pacific is characterized by rapid infrastructure investment, expanding surgical capacity, and a rising middle-class patient base seeking advanced orthopedic care. Local manufacturing and regulatory pathways are increasingly important here, and multinational suppliers frequently pursue partnerships, regional training centers, and tailored product configurations to capture diverse clinical needs and procurement behaviors.

Competitive company strategies that prioritize modular platforms, outcome-aligned service models, and clinical engagement to secure long-term adoption

Leading firms in the arthroscopy domain are converging on a few strategic priorities: system interoperability, lifecycle service offerings, and evidence generation to support clinical value. Companies are investing in modular platforms that allow incremental upgrades to visualization, fluid management, or energy delivery components, which reduces capital replacement barriers for health systems. Service models are evolving from reactive maintenance to predictive support and bundled outcomes-based agreements that align vendor incentives with procedural efficiency and patient recovery metrics.

Competitive differentiation also centers on training and surgeon engagement, with manufacturers expanding simulation-based training programs and proctor networks to accelerate adoption and procedural consistency. Partnerships between device developers and digital health providers aim to incorporate analytics and surgical documentation into clinical workflows, enabling longitudinal outcome tracking and quality improvement. Moreover, strategic alliances with regional distributors, contract manufacturing partners, and academic centers facilitate faster market entry and localized product validation, particularly in markets with unique regulatory or infrastructural challenges.

Actionable recommendations for manufacturers and health systems to strengthen resilience, accelerate clinical adoption, and align value propositions with care delivery priorities

Industry leaders should adopt a multi-pronged strategy that enhances resilience, supports clinical adoption, and aligns commercial models with evolving care delivery needs. First, prioritize modular design and open architecture to enable incremental upgrades and to reduce total cost of ownership for purchasers. This approach lowers barriers to adoption and extends the useful life of installed bases while increasing cross-sell opportunities for adjacent products and consumables.

Second, invest in robust training ecosystems and evidence generation, combining simulation-based curricula with real-world data collection to demonstrate comparative effectiveness and to build surgeon confidence. Third, diversify manufacturing and logistics footprints by exploring nearshoring, dual-sourcing, and strategic inventory buffers that mitigate tariff and supply chain disruptions. Fourth, expand service offerings into outcomes-linked agreements and predictive maintenance to capture recurring revenue and to deepen customer relationships. Finally, tailor regional strategies to account for reimbursement nuance, regulatory timelines, and facility capabilities, ensuring that product configurations and commercial models resonate with local clinical and economic priorities.

Transparent multi-source research methodology combining regulatory review, clinical literature, stakeholder interviews, and technical product assessments to underpin conclusions

The research approach combined a structured review of public regulatory documents, peer-reviewed clinical literature, and device approval notices with targeted primary interviews across surgical, procurement, and executive stakeholders. Device technology assessments relied on technical specifications, product monographs, and supplier disclosures to map feature sets and interoperability characteristics. Regulatory and policy analysis incorporated recent guidance and tariff announcements to assess potential implications for supply chains and cross-border trade.

Qualitative insights were derived from interviews with orthopedic surgeons, ambulatory center managers, and hospital procurement leads to validate use-case assumptions and to surface adoption barriers. Comparative analysis of regional infrastructure and reimbursement environments supported differential strategy recommendations. Throughout, data integrity was maintained by triangulating sources and documenting assumptions used in scenario planning, ensuring transparency in how evidence informed strategic conclusions and recommendations.

Synthesis of cross-cutting trends highlighting the interconnected imperatives of technology, service models, and regional adaptability in arthroscopy

In conclusion, arthroscopy sits at the intersection of technological maturation and care delivery transformation. Advances in visualization, fluid management, and instrumentation are enabling more precise, efficient procedures while outpatient migration and value-driven procurement are reshaping purchasing logic. Supply chain vulnerabilities and policy shifts are accelerating considerations around manufacturing footprint and product architecture, and competitive advantage increasingly depends on service models, training ecosystems, and demonstrable clinical value.

As stakeholders navigate this evolving environment, alignment between product development, clinical evidence generation, and commercial strategy will determine long-term success. Companies that focus on interoperability, regional adaptability, and outcome-oriented service offerings will be best positioned to meet clinician expectations and institutional procurement needs. The conclusions presented here synthesize cross-cutting trends to inform immediate strategic choices and to support longer-term planning for those engaged in arthroscopy device development and deployment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Arthroscopy Market, by Product Type

  • 8.1. Implants
  • 8.2. Instruments
    • 8.2.1. Accessories
    • 8.2.2. Arthroscopes
    • 8.2.3. Pumps
    • 8.2.4. Radiofrequency Probes
    • 8.2.5. Shavers
  • 8.3. Systems
    • 8.3.1. Fluid Management Systems
    • 8.3.2. Rf Systems
    • 8.3.3. Visualization Systems

9. Arthroscopy Market, by Patient Type

  • 9.1. Adults
  • 9.2. Pediatrics

10. Arthroscopy Market, by Application

  • 10.1. Ankle
  • 10.2. Elbow
  • 10.3. Hip
  • 10.4. Knee
  • 10.5. Shoulder
  • 10.6. Wrist

11. Arthroscopy Market, by End User

  • 11.1. Ambulatory Surgery Centers
  • 11.2. Hospitals & Clinics

12. Arthroscopy Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Arthroscopy Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Arthroscopy Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Arthroscopy Market

16. China Arthroscopy Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Arthrex Inc.
  • 17.6. Auxein Medical
  • 17.7. B. Braun Melsungen AG
  • 17.8. Baxter International Inc.
  • 17.9. Bioventus, LLC
  • 17.10. Boston Scientific Corporation
  • 17.11. CONMED Corporation
  • 17.12. Endoch Medical
  • 17.13. Endomed Systems GmbH
  • 17.14. Flexion Therapeutics Inc.
  • 17.15. GPC Medical Ltd.
  • 17.16. Hyalex Orthopaedics, Inc.
  • 17.17. Johnson & Johnson Services Inc.
  • 17.18. Karl Storz SE & Co. KG
  • 17.19. M J Surgical
  • 17.20. Medtronic plc
  • 17.21. Mercator Medical S.A.
  • 17.22. Norm Medical
  • 17.23. Olympus Corporation
  • 17.24. Richard Wolf GmbH
  • 17.25. Shagun Cares Inc.
  • 17.26. Sklar Surgical Instruments
  • 17.27. Smith & Nephew plc
  • 17.28. Stryker Corporation
  • 17.29. Visakha Healthcare India Pvt Ltd
  • 17.30. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTHROSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTHROSCOPY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ARTHROSCOPY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ARTHROSCOPY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTHROSCOPY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ARTHROSCOPY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ARTHROSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ARTHROSCOPY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTHROSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ARTHROSCOPY MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ARTHROSCOPY MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTHROSCOPY MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ARTHROSCOPY MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTHROSCOPY MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ARTHROSCOPY MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTHROSCOPY MARKET SIZE, BY ARTHROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ARTHROSCOPY MARKET SIZE, BY ARTHROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTHROSCOPY MARKET SIZE, BY ARTHROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ARTHROSCOPY MARKET SIZE, BY PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTHROSCOPY MARKET SIZE, BY PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ARTHROSCOPY MARKET SIZE, BY PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTHROSCOPY MARKET SIZE, BY RADIOFREQUENCY PROBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ARTHROSCOPY MARKET SIZE, BY RADIOFREQUENCY PROBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTHROSCOPY MARKET SIZE, BY RADIOFREQUENCY PROBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ARTHROSCOPY MARKET SIZE, BY SHAVERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTHROSCOPY MARKET SIZE, BY SHAVERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ARTHROSCOPY MARKET SIZE, BY SHAVERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTHROSCOPY MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ARTHROSCOPY MARKET SIZE, BY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTHROSCOPY MARKET SIZE, BY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTHROSCOPY MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ARTHROSCOPY MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTHROSCOPY MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ARTHROSCOPY MARKET SIZE, BY RF SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTHROSCOPY MARKET SIZE, BY RF SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ARTHROSCOPY MARKET SIZE, BY RF SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTHROSCOPY MARKET SIZE, BY VISUALIZATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ARTHROSCOPY MARKET SIZE, BY VISUALIZATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTHROSCOPY MARKET SIZE, BY VISUALIZATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTHROSCOPY MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ARTHROSCOPY MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTHROSCOPY MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ARTHROSCOPY MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTHROSCOPY MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ARTHROSCOPY MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ARTHROSCOPY MARKET SIZE, BY ANKLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTHROSCOPY MARKET SIZE, BY ANKLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ARTHROSCOPY MARKET SIZE, BY ANKLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTHROSCOPY MARKET SIZE, BY ELBOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ARTHROSCOPY MARKET SIZE, BY ELBOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTHROSCOPY MARKET SIZE, BY ELBOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ARTHROSCOPY MARKET SIZE, BY HIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTHROSCOPY MARKET SIZE, BY HIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ARTHROSCOPY MARKET SIZE, BY HIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTHROSCOPY MARKET SIZE, BY KNEE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ARTHROSCOPY MARKET SIZE, BY KNEE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTHROSCOPY MARKET SIZE, BY KNEE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ARTHROSCOPY MARKET SIZE, BY SHOULDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTHROSCOPY MARKET SIZE, BY SHOULDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ARTHROSCOPY MARKET SIZE, BY SHOULDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTHROSCOPY MARKET SIZE, BY WRIST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ARTHROSCOPY MARKET SIZE, BY WRIST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTHROSCOPY MARKET SIZE, BY WRIST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTHROSCOPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ARTHROSCOPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTHROSCOPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ARTHROSCOPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ARTHROSCOPY MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ARTHROSCOPY MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTHROSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS ARTHROSCOPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ARTHROSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. GCC ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GCC ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. GCC ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 139. GCC ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 140. GCC ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. GCC ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. GCC ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. G7 ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. G7 ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. G7 ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 160. G7 ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 161. G7 ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. G7 ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. G7 ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. NATO ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. NATO ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. NATO ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 167. NATO ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 168. NATO ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. NATO ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. NATO ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES ARTHROSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA ARTHROSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)